Author:
Sgouros George,Hobbs Robert F.
Subject
Radiology, Nuclear Medicine and imaging
Reference78 articles.
1. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin’s lymphoma;Witzig;J Clin Oncol,2002
2. A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas;Press;Blood,2000
3. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs;Kwekkeboom;J Nucl Med.,2005
4. Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues;Bodei;Eur Rev Med Pharmacol Sci,2010
5. Targeting RAF: Trials and tribulations;Downward;Nat Med,2011
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献